# [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease

> **NCT02656498** · PHASE2 · COMPLETED · sponsor: **Jae Seung Kim** · enrollment: 135 (actual)

## Conditions studied

- Alzheimer's Disease
- Mild Cognitive Impairment
- Neurodegenerative Diseases

## Interventions

- **DRUG:** [18F]THK-5351

## Key facts

- **NCT ID:** NCT02656498
- **Lead sponsor:** Jae Seung Kim
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-11
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2020-12-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656498, "[18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02656498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*